HB Meth 1gm Injection contains Methylprednisolone 1000mg, a synthetic corticosteroid with potent anti-inflammatory and immunosuppressive properties. It is indicated for the management of various inflammatory and autoimmune conditions, including severe allergic reactions, acute exacerbations of multiple sclerosis, rheumatoid arthritis, systemic lupus erythematosus, and certain dermatologic, hematologic, and respiratory disorders. Methylprednisolone exerts its therapeutic effects by modulating the immune response and inhibiting the release of inflammatory mediators, thereby reducing tissue inflammation and immune system activity. The injection is administered intravenously or intramuscularly, allowing rapid onset of action, especially in acute or severe clinical situations requiring immediate intervention. Dosage and duration of therapy should be individualized based on the patient’s condition, response to treatment, and clinical guidelines. Caution is advised in patients with infections, diabetes mellitus, hypertension, osteoporosis, or gastrointestinal disorders, as corticosteroids may exacerbate these conditions. Common adverse effects include hyperglycemia, fluid retention, hypertension, mood changes, and increased susceptibility to infections. HB Meth 1gm Injection should be used under strict medical supervision, with monitoring for potential side effects and periodic assessment of therapeutic efficacy. It is contraindicated in systemic fungal infections and known hypersensitivity to corticosteroids.